The global fluid management systems market accounted for USD 11.34 billion in 2023 and is expected to reach USD 47.08 billion by 2034 with a CAGR of 13.82% during the forecast period 2024-2034. Increased focus on infection control and patient safety, a rise in minimally invasive surgeries, government initiatives, and healthcare reforms, an increase in surgical procedures and diagnostic tests, and the expansion of healthcare infrastructure in emerging markets will all contribute to the market's growth.
Minimally invasive surgical methods are becoming more and more popular than standard open operations because of advantages like quicker recovery periods, fewer issues after surgery, and less expensive healthcare. Fluid management systems, which offer precise control over irrigation, insufflation, and suction, are essential to minimally invasive treatments including laparoscopy, arthroscopy, and endoscopy. For instance, Transit Scientific reported in April 2022 that the FDA has cleared its XO Cross Support catheter device for use in coronary procedures. This platform is intended to facilitate wire exchange, guide and support the guidewire during access to the peripheral or coronary arteries, and offer assistance for the administration of diagnostic or saline contrast chemicals.
By product, the dialyzers segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the rising global need for dialysis therapy due to the incidence of end-stage renal illness and chronic kidney disease. For instance, in February 2022, Medtronic plc declared that the FDA had approved the first and only ablation catheters, the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters, to treat the increasing number of pediatric cases of Atrioventricular Nodal Reentrant Tachycardia (AVNRT). Additionally, the insufflators segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of minimally invasive surgical procedures and technological advancements in insufflation systems.
By disposables and accessories, the catheters segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing prevalence of urinary tract disorders and the growing demand for catheter-based interventions in urological procedures. For instance, the Bodyport cardiac scale received approval for fluid management assessment from the US Food and Drug Administration in August 2022. Additionally, the tubing sets segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for disposable tubing sets, technological advancements, and the increasing number of surgical procedures requiring fluid management.
By application, the urology segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing prevalence of urological disorders such as kidney stones, urinary incontinence, and prostate enlargement, driving the demand for urology-specific fluid management systems. For instance, Becton, Dickinson, and Company (BD)/Carefusion 303 recalled Alaris infusion pumps in December 2023 because of problems with their compatibility with Cardinal Health Monoject syringes. Additionally, the laparoscopy segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of minimally invasive surgical techniques, advancements in laparoscopic procedures, and the increasing prevalence of laparoscopic surgeries across various medical specialties.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing demand for advanced medical technologies, rising surgical volumes, and the growing emphasis on efficient patient care in hospital settings. For instance, Zynex, Inc., a medical technology company that specializes in the production and distribution of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced in June 2023 that the FDA had approved the 510(k) for the company's CM-1600 blood and fluid volume monitoring device. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for outpatient procedures, advancements in ambulatory surgical techniques, and the need for cost-effective healthcare delivery models.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of chronic diseases in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising adoption of advanced medical technologies in emerging economies such as China, India, and Japan. For instance, Transit Scientific reported in April 2022 that the FDA had cleared its XO Cross Support catheter platform for use in coronary procedures. This platform is intended to facilitate wire exchange, guide and support the guidewire during access to the peripheral or coronary arteries, and offer assistance for the administration of diagnostic or saline contrast chemicals.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Minimally invasive surgical methods are becoming more and more popular than standard open operations because of advantages like quicker recovery periods, fewer issues after surgery, and less expensive healthcare. Fluid management systems, which offer precise control over irrigation, insufflation, and suction, are essential to minimally invasive treatments including laparoscopy, arthroscopy, and endoscopy. For instance, Transit Scientific reported in April 2022 that the FDA has cleared its XO Cross Support catheter device for use in coronary procedures. This platform is intended to facilitate wire exchange, guide and support the guidewire during access to the peripheral or coronary arteries, and offer assistance for the administration of diagnostic or saline contrast chemicals.
By product, the dialyzers segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the rising global need for dialysis therapy due to the incidence of end-stage renal illness and chronic kidney disease. For instance, in February 2022, Medtronic plc declared that the FDA had approved the first and only ablation catheters, the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters, to treat the increasing number of pediatric cases of Atrioventricular Nodal Reentrant Tachycardia (AVNRT). Additionally, the insufflators segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of minimally invasive surgical procedures and technological advancements in insufflation systems.
By disposables and accessories, the catheters segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing prevalence of urinary tract disorders and the growing demand for catheter-based interventions in urological procedures. For instance, the Bodyport cardiac scale received approval for fluid management assessment from the US Food and Drug Administration in August 2022. Additionally, the tubing sets segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for disposable tubing sets, technological advancements, and the increasing number of surgical procedures requiring fluid management.
By application, the urology segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing prevalence of urological disorders such as kidney stones, urinary incontinence, and prostate enlargement, driving the demand for urology-specific fluid management systems. For instance, Becton, Dickinson, and Company (BD)/Carefusion 303 recalled Alaris infusion pumps in December 2023 because of problems with their compatibility with Cardinal Health Monoject syringes. Additionally, the laparoscopy segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of minimally invasive surgical techniques, advancements in laparoscopic procedures, and the increasing prevalence of laparoscopic surgeries across various medical specialties.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global fluid management systems market in 2023 owing to the increasing demand for advanced medical technologies, rising surgical volumes, and the growing emphasis on efficient patient care in hospital settings. For instance, Zynex, Inc., a medical technology company that specializes in the production and distribution of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced in June 2023 that the FDA had approved the 510(k) for the company's CM-1600 blood and fluid volume monitoring device. Additionally, the ambulatory surgery centers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing preference for outpatient procedures, advancements in ambulatory surgical techniques, and the need for cost-effective healthcare delivery models.
North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of chronic diseases in the region. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising adoption of advanced medical technologies in emerging economies such as China, India, and Japan. For instance, Transit Scientific reported in April 2022 that the FDA had cleared its XO Cross Support catheter platform for use in coronary procedures. This platform is intended to facilitate wire exchange, guide and support the guidewire during access to the peripheral or coronary arteries, and offer assistance for the administration of diagnostic or saline contrast chemicals.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Disposables and Accessories, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Fluid Management Systems Market Report 2023 - 2034
Fluid Management Systems Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Dialyzers
- Insufflators
- Suction and Irrigation Systems
- Fluid Warming Systems
- Fluid Waste Management
- Other Products
Fluid Management Systems Market Analysis & Forecast by Disposables and Accessories 2023 - 2034 (Revenue USD Bn)
- Catheters
- Bloodlines
- Transducers
- Valves
- Tubing Sets
- Other Disposables and Accessories
Fluid Management Systems Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Arthroscopy
- Laparoscopy
- Neurology
- Cardiology
- Urology
- Dental
- Gastroenterology
- Other Applications
Fluid Management Systems Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Diagnostic Centers
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
Fluid Management Systems Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Fluid Management Systems Market: Product Estimates & Trend Analysis
8. Fluid Management Systems Market: Disposables and Accessories Estimates & Trend Analysis
9. Fluid Management Systems Market: Application Estimates & Trend Analysis
10. Fluid Management Systems Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Fluid Management Systems Market
13. Europe Global Fluid Management Systems Market
14. Asia Pacific Global Fluid Management Systems Market
15. Latin America Global Fluid Management Systems Market
16. MEA Global Fluid Management Systems Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Medical Care AG & Co. KGaA
- Stryker Corporation
- Smiths Group plc
- Medtronic plc
- Cardinal Health Inc.
- Olympus Corporation
- Karl Storz SE & Co. KG
- ConMed Corporation
- AngioDynamics Inc.
- Zimmer Biomet Holdings Inc.
- Teleflex Incorporated
- Becton
- Dickinson and Company
- ICU Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 11.34 Billion |
| Forecasted Market Value ( USD | $ 47.08 Billion |
| Compound Annual Growth Rate | 13.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
